Interviews with Key Healthcare Opinion Leaders - Episode #74

By Tamara Thomas - Last Updated: April 5, 2024

Andrew Hertler, MD, talks about the importance of prophylactic mastectomy for individuals carrying high-risk BRCA1, BRCA2, and other deleterious gene mutations.

Advertisement

Related Podcasts

Interviews with Key Healthcare Opinion Leaders - Episode #88
Interviews with Key Healthcare Opinion Leaders - Episode #87
Interviews with Key Healthcare Opinion Leaders - Episode #86
Interviews with Key Healthcare Opinion Leaders - Episode #85
Interviews with Key Healthcare Opinion Leaders - Episode #84
Advertisement
Advertisement
Latest News

Trust in Medical Information Sources Varies by Race and Ethnicity

December 20, 2024

Dr. Kamal Golla on how to Improve Primary Care Physician and Specialist Coordination and Engagement

December 20, 2024

Gaps in Clinical Trial Access Affect Veterans With Prostate Cancer

December 19, 2024

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • Who We Are

    About Us

    Editorial Policy

    Contributors & Partners

    Connect

    eNewsletters

    Contact Us

    Work With Us

    Advertising

    Our Network

    GU Oncology Now

    Blood Cancers Today

    Cancer Nursing Today

    DocWire News

    MashupMD

    © 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |